We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.47B
AUM Growth
-$26.4M
Cap. Flow
-$317M
Cap. Flow %
-3.74%
Top 10 Hldgs %
16.75%
Holding
2,295
New
113
Increased
604
Reduced
562
Closed
131

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$44.9M
2
BKNG icon
Booking.com
BKNG
+$30.5M
3
TWX
Time Warner Inc
TWX
+$22.2M
4
MON
Monsanto Co
MON
+$15.5M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 17.18%
2 Financials 16.58%
3 Healthcare 12.69%
4 Industrials 10.83%
5 Consumer Discretionary 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSTI icon
2101
SoundThinking
SSTI
$105M
$137K ﹤0.01%
+3,603
New +$116K
SEI
2102
Solaris Energy Infrastructure
SEI
$3.87B
$137K ﹤0.01%
9,598
CTIC
2103
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$137K ﹤0.01%
+27,473
New +$120K
CCBG icon
2104
Capital City Bank Group
CCBG
$888M
$136K ﹤0.01%
5,769
ITIC
2105
Investors Title Co
ITIC
$535M
$136K ﹤0.01%
736
NATH icon
2106
Nathan's Famous
NATH
$399M
$136K ﹤0.01%
+1,450
New +$120K
PLPC icon
2107
Preformed Line Products
PLPC
$2.35B
$136K ﹤0.01%
+1,536
New +$114K
RDI icon
2108
Reading International Class A
RDI
$33.2M
$136K ﹤0.01%
8,504
BREW
2109
DELISTED
Craft Brew Alliance, Inc.
BREW
$136K ﹤0.01%
6,574
ATEN icon
2110
A10 Networks
ATEN
$1.97B
$135K ﹤0.01%
21,727
EPM icon
2111
Evolution Petroleum
EPM
$135M
$135K ﹤0.01%
+13,703
New +$126K
MITK icon
2112
Mitek Systems
MITK
$836M
$135K ﹤0.01%
15,125
NERV icon
2113
Minerva Neurosciences
NERV
$206M
$135K ﹤0.01%
+2,038
New +$124K
AXTI icon
2114
AXT Inc
AXTI
$4.83B
$134K ﹤0.01%
18,990
+13,069
+221% +$91.2K
SYRS
2115
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$134K ﹤0.01%
+1,311
New +$162K
AVHI
2116
DELISTED
A V Homes, Inc.
AVHI
$134K ﹤0.01%
+6,263
New +$119K
GOGO icon
2117
Gogo Inc
GOGO
$392M
$133K ﹤0.01%
27,419
SHOE
2118
Shoe Station Group
SHOE
$428M
$133K ﹤0.01%
8,228
WATT icon
2119
Energous
WATT
$103M
$133K ﹤0.01%
15
FRAN
2120
DELISTED
Francesca's Holdings Corporation
FRAN
$133K ﹤0.01%
+1,472
New +$101K
BATRA icon
2121
Atlanta Braves Holdings Series A
BATRA
$3.49B
$131K ﹤0.01%
+5,080
New +$122K
COOP
2122
DELISTED
Mr. Cooper
COOP
$131K ﹤0.01%
8,172
GEF.B icon
2123
Greif Class B
GEF.B
$4.23B
$131K ﹤0.01%
2,277
GNTY
2124
DELISTED
Guaranty Bancshares
GNTY
$131K ﹤0.01%
4,374
SRGA
2125
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$130K ﹤0.01%
945

Similar funds

MetLife Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, MetLife Investment Management held 2,295 positions worth $8.47B, down 0.31% from $8.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management withdrew a net $317M in Q2 2018, closing 131 positions and reducing 562 holdings. Its most notable exit was DuPont de Nemours, an estimated $44.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in Bank of New York Mellon worth $16M.

  • MetLife Investment Management's largest Q2 2018 buy was Bank of New York Mellon: 297,519 shares worth $16M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $33.8M increase.
  • MetLife Investment Management's biggest Q2 2018 reduction was Apple, cutting an estimated $14.5M.
  • MetLife Investment Management fully exited DuPont de Nemours in Q2 2018, selling an estimated $44.9M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $8.47B portfolio in Q2 2018.
  • MetLife Investment Management opened 113 new positions and closed 131 in Q2 2018.
  • MetLife Investment Management's portfolio value fell 0.31% quarter-over-quarter to $8.47B.

Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.